English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

STN-DBS activates the target area in Parkinson disease. An FDG-PET study

MPS-Authors
/persons/resource/persons147216

Kracht,  Lutz W.
Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147188

Heiss,  Wolf-Dieter
Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Hilker, R., Voges, J., Weber, T., Kracht, L. W., Roggendorf, J., Baudrexel, S., et al. (2008). STN-DBS activates the target area in Parkinson disease. An FDG-PET study. Neurology, 71(10), 708-713.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D952-7
Abstract
Copyright (c) 2008 by AAN Enterprises, Inc.